Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Watson to buy drug delivery company TheraTech in stock swap

Executive Summary

Watson Pharmaceuticals (proprietary and off-patent drugs) will buy drug delivery company TheraTech in a stock swap that values TheraTech at about $300mm. The companies expect the transaction to close in the first quarter of 1999.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Pulmonary
      • Transdermal
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register